Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Financial Flexibility Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥18.27 Million (operating CF CN¥-26.19 Million minus capex CN¥44.45 Million) represents 0% of total liabilities (CN¥181.12 Million). Check how resilient are Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 7 annual periods. See 301089 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
Year-by-year free cash flow to debt coverage for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For the full company profile including market capitalisation, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.10x | CN¥18.27 Million | CN¥-26.19 Million | CN¥181.12 Million | ▼ -88.9% |
| 2024 | 0.91x | CN¥186.58 Million | CN¥102.67 Million | CN¥205.72 Million | ▲ +0.8% |
| 2023 | 0.90x | CN¥212.17 Million | CN¥26.95 Million | CN¥235.72 Million | ▲ +0.7% |
| 2022 | 0.89x | CN¥417.18 Million | CN¥268.85 Million | CN¥466.89 Million | ▲ +54.9% |
| 2021 | 0.58x | CN¥170.92 Million | CN¥58.19 Million | CN¥296.35 Million | ▲ +35.4% |
| 2020 | 0.43x | CN¥194.12 Million | CN¥120.00 Million | CN¥455.61 Million | ▼ -6.5% |
| 2019 | 0.46x | CN¥162.58 Million | CN¥86.38 Million | CN¥356.74 Million | — |